Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

Detalhes bibliográficos
Principais autores:	Harrison, G, Richards, S, Lawson, S, Darbyshire, P, Pinkerton, R, Stevens, R, Oakhill, A, Eden, O
Formato:	Journal article
Idioma:	English
Publicado em:	2000

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
por: Harrison, G, et al.
Publicado em: (2000)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
por: Chessels, J, et al.
Publicado em: (1997)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
por: Chessells, J, et al.
Publicado em: (1995)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
por: Chessells, J, et al.
Publicado em: (1994)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
por: Chessells, J, et al.
Publicado em: (1997)

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.
por: Secker-Walker, L, et al.
Publicado em: (1997)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
por: Wheeler, K, et al.
Publicado em: (1998)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
por: Wheeler, K, et al.
Publicado em: (1998)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
por: Kinsey, S, et al.
Publicado em: (2002)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
por: Hann, I, et al.
Publicado em: (2000)

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
por: Chessells, J, et al.
Publicado em: (1992)

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
por: Webb, D, et al.
Publicado em: (1999)

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties.
por: Chessells, J, et al.
Publicado em: (1998)

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
por: Chessells, J, et al.
Publicado em: (2002)

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
por: Wheeler, K, et al.
Publicado em: (1996)

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.
por: Lawson, SE, et al.
Publicado em: (2000)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
por: Hann, I, et al.
Publicado em: (1998)

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.
por: Halsey, C, et al.
Publicado em: (2011)

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI
por: Vargha-Khadem Faraneh, et al.
Publicado em: (2011-10-01)

Late relapsing childhood lymphoblastic leukaemia.
por: Frost, L, et al.
Publicado em: (1997)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
por: Moor-Man, A, et al.
Publicado em: (2009)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
por: Eden, O, et al.
Publicado em: (1991)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
por: Sive, J, et al.
Publicado em: (2012)

Adult patients with acute lymphoblastic leukaemia (ALL) who relapse have a dismal outlook: Results from MRC UKALL XII/ECOG 2993 trial.
por: Chopra, R, et al.
Publicado em: (2003)

Late relapsing childhood acute lymphoblastic leukaemia.
por: Frost, L, et al.
Publicado em: (1998)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
por: Somervaille, T, et al.
Publicado em: (2003)

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
por: Chessells, J, et al.
Publicado em: (1986)

HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial.
por: Taylor, G, et al.
Publicado em: (2012)

No association of HLA-A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial.
por: Thompson, P, et al.
Publicado em: (2011)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
por: Lilleyman, J, et al.
Publicado em: (1988)

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
por: Lilleyman, J, et al.
Publicado em: (1992)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
por: Vora, A, et al.
Publicado em: (2008)

Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukaemia in Adults.
por: Catovsky, D, et al.
Publicado em: (1989)

Influence of HLA-DP supertype on the survival of childhood acute lymphoblastic leukaemia: analysis of the UKALL X1 trial
por: Taylor, G, et al.
Publicado em: (2008)

Clinical effect of Imatinib following remission induction in adult Philadelphia chromosome-positive acute lymphoblastic leukaemia: early results from the MRC UKALL12 Study
por: Patel, B, et al.
Publicado em: (2006)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
por: Eden, O, et al.
Publicado em: (1990)

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
por: Vora, A, et al.
Publicado em: (2008)

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
por: Burnett, A, et al.
Publicado em: (2002)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
por: Chessells, J, et al.
Publicado em: (1995)

Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.
por: Lilleyman, J, et al.
Publicado em: (1994)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.

Registros relacionados

Registros relacionados